text_combined: still growing one still growing get vivo medical surges momentummomentum traders ivvo substantial trading volumexgno stock moving active traders take note ivvo 50 10 trading sessions miss another day gains massive promotional campaign ongoing additional news coming yv know ivvo works trading activity anyindication company could moving much higher short outstanding 5 020 000 last 10 qsb filing market capitalization 10 542 000 12 17 04 impressive gains past week beginiing vivo medical diagnostics inc stock symbol otc ivvo finalizing first ground breaking portable medical device prothrombin time monitor measures changes magnetic fields blood molecular level critical patients undergoing anticoagulation therapy heart attacks strokes measurement portable used real time achieve optimal medication levels essential successful treatment ivvo recently announced joint effort inverness medical innovations leading manufacturer marketer rapid diagnostic products order complete development prothrombin time monitor clinical trials prothrombin testing massive market continues grow projections excess 150 million 2005 500 million 2010 ivvo poised capitalize significant opportunity dont miss near term upside potential ivvo investment anaysis imzx vivo medical diagnostics inc stock symbol otc ivvo short term target 3 00 4 00 12 month target 6 00 7 00 recommendations strong buy long term outlook excellent industryhrnq heart disease common cause death cardiovascular disease affects 60 million people worldwide largest area growth health care sector patient management growth caused patients chronic conditions forced make frequent costly hospital visits monitor condition ks ivvo ivvo well established company operating eight years ivvo currently two additional products 2 nd clinical trials pregnancy labor monitor fetal heart rate monitor along 12 patents allow extend technology emerging medical solutions ivvo currently profitable additional royalty income beginning 2005 ivvo sufficient funds hand take well 2006 ivvo momentum play incredible short term potential risk adverse traders take note information within email contains forward looking statements within meaning section 27 securities act 1933 section 21 b securities exchange act 1934 statements express involve discussions respect predictions goals expectations beliefs plans projections objectives assumptions future events performance statements historical fact may forward looking statements please advised nothing within email shall constitute solicitation offer buy sell security mentioned herein newsletter neither registered investment advisor affiliated broker dealer newsletter affiliated vivo medical diagnostics newsletter produced distributed independent third party john howard compensated 7500 dollars express distribute opinion e mail statements made express opinion treated may buy sell securities mentioned time report includes forward looking statements within meaning private securities litigation reform act 1995 statements may include terms expect believe may move undervalued intend similar terms please due diligence investing profiled company may lose money investing penny stocks